IRONNET INC (IRNT) Fundamental Analysis & Valuation

NYSE:IRNTUS46323Q1058

Current stock price

0.127 USD
-0.01 (-6.55%)
At close:
0.13 USD
+0 (+2.36%)
After Hours:

This IRNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IRNT Profitability Analysis

1.1 Basic Checks

  • IRNT had negative earnings in the past year.
  • In the past year IRNT has reported a negative cash flow from operations.
IRNT Yearly Net Income VS EBIT VS OCF VS FCFIRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

  • IRNT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IRNT Yearly ROA, ROE, ROICIRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

  • IRNT's Gross Margin of 33.25% is on the low side compared to the rest of the industry. IRNT is outperformed by 81.79% of its industry peers.
  • In the last couple of years the Gross Margin of IRNT has declined.
  • IRNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
IRNT Yearly Profit, Operating, Gross MarginsIRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600 -800

0

2. IRNT Health Analysis

2.1 Basic Checks

  • IRNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IRNT has more shares outstanding
  • IRNT has a worse debt/assets ratio than last year.
IRNT Yearly Shares OutstandingIRNT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
IRNT Yearly Total Debt VS Total AssetsIRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -32.87, we must say that IRNT is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -32.87, IRNT is doing worse than 95.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -32.87
ROIC/WACCN/A
WACC10.18%
IRNT Yearly LT Debt VS Equity VS FCFIRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M -40M -60M -80M

2.3 Liquidity

  • IRNT has a Current Ratio of 0.38. This is a bad value and indicates that IRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IRNT has a worse Current ratio (0.38) than 94.64% of its industry peers.
  • IRNT has a Quick Ratio of 0.38. This is a bad value and indicates that IRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IRNT has a worse Quick ratio (0.33) than 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.33
IRNT Yearly Current Assets VS Current LiabilitesIRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

2

3. IRNT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 59.06% over the past year.
  • Looking at the last year, IRNT shows a very negative growth in Revenue. The Revenue has decreased by -19.64% in the last year.
  • IRNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%

3.2 Future

  • IRNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.90% yearly.
  • IRNT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.78% yearly.
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IRNT Yearly Revenue VS EstimatesIRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IRNT Yearly EPS VS EstimatesIRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8

1

4. IRNT Valuation Analysis

4.1 Price/Earnings Ratio

  • IRNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRNT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRNT Price Earnings VS Forward Price EarningsIRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRNT Per share dataIRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IRNT's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3YN/A

0

5. IRNT Dividend Analysis

5.1 Amount

  • No dividends for IRNT!.
Industry RankSector Rank
Dividend Yield N/A

IRNT Fundamentals: All Metrics, Ratios and Statistics

IRONNET INC

NYSE:IRNT (8/4/2023, 8:11:34 PM)

After market: 0.13 +0 (+2.36%)

0.127

-0.01 (-6.55%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-15
Earnings (Next)09-12
Inst Owners0%
Inst Owner Change0%
Ins Owners26.14%
Ins Owner Change0%
Market Cap14.20M
Revenue(TTM)27.26M
Net Income(TTM)-111.01M
Analysts36.67
Price Target0.15 (18.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.28%
Min Revenue beat(2)8.29%
Max Revenue beat(2)10.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.55%
Min Revenue beat(4)-14.19%
Max Revenue beat(4)10.28%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0.24
BVpS-0.31
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.33
Altman-Z -32.87
F-Score4
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)147.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.48%
OCF growth 3YN/A
OCF growth 5YN/A

IRONNET INC / IRNT Fundamental Analysis FAQ

What is the fundamental rating for IRNT stock?

ChartMill assigns a fundamental rating of 1 / 10 to IRNT.


Can you provide the valuation status for IRONNET INC?

ChartMill assigns a valuation rating of 1 / 10 to IRONNET INC (IRNT). This can be considered as Overvalued.


What is the profitability of IRNT stock?

IRONNET INC (IRNT) has a profitability rating of 0 / 10.


What is the expected EPS growth for IRONNET INC (IRNT) stock?

The Earnings per Share (EPS) of IRONNET INC (IRNT) is expected to grow by 33.33% in the next year.